Koers Vertex Pharmaceuticals Incorporated
Aandelen
VRTX
US92532F1003
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
418 USD | +0,17% | +0,55% | +2,73% |
Omzet 2024 * | 10,73 mld. 9,96 mld. | Omzet 2025 * | 11,74 mld. 10,89 mld. | Marktkapitalisatie | 108 mld. 100 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 3,9 mld. 3,61 mld. | Nettowinst (verlies) 2025 * | 4,5 mld. 4,17 mld. | EV/omzet 2024 * | 8,47 x |
Nettoliquiditeiten 2024 * | 17,11 mld. 15,88 mld. | Nettoliquiditeiten 2025 * | 21,54 mld. 19,98 mld. | EV/omzet 2025 * | 7,36 x |
K/w-verhouding 2024 * |
27,8
x | K/w-verhouding 2025 * |
24,2
x | Werknemers | 5.400 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,89% |
Recentste transcriptie over Vertex Pharmaceuticals Incorporated
1 dag | +0,17% | ||
1 week | +0,55% | ||
Lopende maand | -0,65% | ||
1 maand | -2,10% | ||
3 maanden | +2,14% | ||
6 maanden | +18,58% | ||
Lopend jaar | +2,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 51 | 01-02-17 | |
Jeffrey Leiden
CHM | Chairman | 68 | 08-07-09 |
Charles Wagner
DFI | Director of Finance/CFO | 55 | 10-04-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alan Garber
BRD | Director/Board Member | 68 | 08-06-17 |
Jeffrey Leiden
CHM | Chairman | 68 | 08-07-09 |
Bruce Sachs
BRD | Director/Board Member | 64 | 01-01-98 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
7.67% | 0 M€ | 0,00% | - | |
7.08% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 418 | +0,17% | 1 092 126 |
27-03-24 | 417,3 | -0,27% | 905 446 |
26-03-24 | 418,5 | +0,58% | 952 561 |
25-03-24 | 416 | +0,09% | 732 827 |
22-03-24 | 415,7 | -0,01% | 821 734 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,73% | 108 mld. | |
+9,59% | 104 mld. | |
+6,58% | 23,66 mld. | |
-12,59% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,36% | 18,2 mld. | |
-13,29% | 16,19 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,22 mld. | |
-6,78% | 10,36 mld. |